AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 211 filers reported holding AMICUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $329,000 | -66.1% | 34,534 | -64.9% | 0.03% | -63.4% |
| Q1 2021 | $970,000 | +170.2% | 98,248 | +531.2% | 0.08% | +182.8% |
| Q4 2020 | $359,000 | -62.7% | 15,566 | -75.6% | 0.03% | -70.7% |
| Q2 2020 | $962,000 | +70.9% | 63,849 | +54.2% | 0.10% | +200.0% |
| Q1 2019 | $563,000 | -72.8% | 41,400 | -68.7% | 0.03% | -23.3% |
| Q2 2018 | $2,068,000 | +115.9% | 132,400 | +107.8% | 0.04% | +152.9% |
| Q1 2018 | $958,000 | -56.2% | 63,700 | -58.1% | 0.02% | -46.9% |
| Q4 2017 | $2,187,000 | +11.8% | 152,000 | -21.8% | 0.03% | +10.3% |
| Q2 2017 | $1,957,000 | – | 194,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |